0001123292-19-000749.txt : 20190513
0001123292-19-000749.hdr.sgml : 20190513
20190513193215
ACCESSION NUMBER: 0001123292-19-000749
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190513
FILED AS OF DATE: 20190513
DATE AS OF CHANGE: 20190513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CANAAN X L.P.
CENTRAL INDEX KEY: 0001619859
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38905
FILM NUMBER: 19820098
BUSINESS ADDRESS:
STREET 1: 285 RIVERSIDE AVE.
STREET 2: SUITE 250
CITY: WESTPORT
STATE: CT
ZIP: 06880
BUSINESS PHONE: 203-855-0400
MAIL ADDRESS:
STREET 1: 285 RIVERSIDE AVE.
STREET 2: SUITE 250
CITY: WESTPORT
STATE: CT
ZIP: 06880
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Canaan Partners X LLC
CENTRAL INDEX KEY: 0001673228
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38905
FILM NUMBER: 19820099
BUSINESS ADDRESS:
STREET 1: 2765 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 6508548092
MAIL ADDRESS:
STREET 1: 2765 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NextCure, Inc.
CENTRAL INDEX KEY: 0001661059
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 475231247
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9000 VIRGINIA MANOR ROAD, SUITE 200
CITY: BELTSVILLE
STATE: MD
ZIP: 20705
BUSINESS PHONE: 240-399-4900
MAIL ADDRESS:
STREET 1: 9000 VIRGINIA MANOR ROAD, SUITE 200
CITY: BELTSVILLE
STATE: MD
ZIP: 20705
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-05-13
1
0001661059
NextCure, Inc.
NXTC
0001619859
CANAAN X L.P.
C/O CANAAN PARTNERS
285 RIVERSIDE AVENUE, SUITE 250
WESTPORT
CT
06880
0
0
1
0
0001673228
Canaan Partners X LLC
C/O CANAAN PARTNERS
285 RIVERSIDE AVENUE, SUITE 250
WESTPORT
CT
06880
0
0
1
0
Common Stock
2019-05-13
4
C
0
445866
A
445866
D
Common Stock
2019-05-13
4
C
0
743110
A
1188976
D
Common Stock
2019-05-13
4
C
0
729599
A
1918575
D
Common Stock
2019-05-13
4
C
0
285867
A
2204442
D
Common Stock
2019-05-13
4
P
0
50000
15.00
A
2254442
D
Series A-1 Preferred Stock
2019-05-13
4
C
0
3582000
D
Common Stock
445866
0
D
Series A-2 Preferred Stock
2019-05-13
4
C
0
5970000
D
Common Stock
743110
0
D
Series A-3 Preferred Stock
2019-05-13
4
C
0
5861455
D
Common Stock
729599
0
D
Series B-1 Preferred Stock
2019-05-13
4
C
0
2296605
D
Common Stock
285867
0
D
The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date.
The shares are held directly by Canaan X L.P. (the "Canaan Fund"). The sole general partner of the Canaan Fund is Canaan Partners X LLC ("Canaan X"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Investment and voting decisions with respect to the shares held by the Canaan Fund are made by the managers of Canaan X, collectively. Canaan X disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.
Exhibit 24 - Power of Attorney (incorporated herein by reference to the Power of Attorney filed as Exhibit 24 to the Form 3 filed by the Reporting Persons on May 8, 2019)
Canaan X L.P.,
By: Canaan Partners X LLC, its general partner,
By: /s/ Janine MacDonald, Attorney-in-Fact
2019-05-13
Canaan Partners X LLC, By: /s/ Janine MacDonald, Attorney-in-Fact
2019-05-13